Sino Biopharmaceutical (OTCMKTS:SBMFF) Trading Down 12.3% – Here’s What Happened

Shares of Sino Biopharmaceutical Limited (OTCMKTS:SBMFFGet Free Report) were down 12.3% during trading on Thursday . The company traded as low as $0.37 and last traded at $0.37. Approximately 202 shares changed hands during trading, a decline of 95% from the average daily volume of 4,229 shares. The stock had previously closed at $0.42.

Sino Biopharmaceutical Stock Down 12.3 %

The firm’s fifty day simple moving average is $0.42 and its 200 day simple moving average is $0.41.

About Sino Biopharmaceutical

(Get Free Report)

Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand.

Featured Articles

Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.